Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

The UGR Hill House The First Research Laboratory To Study Risk Conducts When Driving Motorcycles
The University of Granada will house the first European research centre on teenagers" mental mechanisms when driving motorcycles and carrying out risk conducts, which could be helpful, in a near future, to modify and avoid them. The Faculty of Psychology will house three state-of-the-art simulators there was already one at the UGR so far- that will be useful to do research into these mechanisms, thanks to an agreement signed with the company Honda Motor Co. (Europe); the University will become one of the most important centres around the world in this subject.

Illinois Attorney General Files Lawsuit Against HIV/AIDS Nonprofit
The Illinois attorney general on Thursday filed a lawsuit against the Center for AIDS Prevention for unlawful fundraising and falsifying official documents, ProPublica reports (Weaver, 7/27). Attorney General Lisa Madigan said the state revoked the organization"s registration 20 years ago, but its director, Steve Neely, also known as Morrell Neely, has continued to solicit donations in the state. "The state says the group tried to reregister as a nonprofit using a phony Chicago address, though its boss, ò€¦ lives in Riverside, Calif.," Courthouse News Service reports (Freeland, 7/27). "If the suit is successful, Illinois could seize money illegally raised there, bar Neely and others involved with the center from future charitable work in the state, freeze their assets, force them to pay back donations they may have "misused and/or wasted" with interest, and attempt to shut the group down for good by revoking its corporate status," ProPublica reports (7/27).
News of the day
H1N1 Could Infect Up To 2B People Within Next Two Years, WHO Says
The WHO on Friday said the "H1N1 swine-flu virus could infect up to two billion people over the next two years - about one of every three people in the world," VOA News reports. According to the news service, "A separate WHO report Friday said the virus has spread to almost every country in the world, killing about 800 people since it emerged in April" (7/25).
Public Health

Autism-Mitochondrial Study: Participants Needed

ASD Centers, LLC has expanded the clinical study started in the Dallas, Texas area to include other locations. This study is designed to examine mitochondrial dysfunction and how L-carnitine supplementation affects behavior, cognition, muscle strength, and health/physical traits in those with a diagnosed autism spectrum disorder (ASD). Study Background L-carnitine is a naturally occurring amino acid required in energy metabolism. Carnitine is essential for the utilization of fatty acids to produce the energy needed to sustain cell function. Carnitine deficiency is commonly found in children who have a diagnosis in the autism spectrum. Mitochondrial dysfunction is also often found in those diagnosed with autism. And carnitine has been used to treat mitochondrial dysfunction. Design of This Study Participants: Thirty children 3-10 years of age (they can be older than ten if they weigh less than 100 pounds), who have a diagnosis of autism, PDD-NOS, or other ASD or pervasive developmental disorder. They cannot have had carnitine-based therapy, or methionine or lysine supplementation, or seizures. Study: Two-thirds of the children that participate in the study will receive treatment and one-third will receive a placebo. The study period is 3 months. Blood work and muscle strength testing will be done before and after treatment. The product is citrus flavored and taken orally. There will be no costs to the participants. For more information or if you would like to participate, please contact the location nearest you: - Janet Kern, Coordinating Director, at: 214-592-6600 [Genetic Consultants of Dallas: 408 N. Allen Dr., Allen, Texas 75013-2500], or - David Geier at: 410-581-8300 [Genetic Consultants of Baltimore: 20 Crossroads Dr., Suite 211, Owings Mills, MD 21117], - David Geier at: 301-770-5300 [Genetic Consultants of Washington, DC: 11125 Rockville Pike, Suite 302, Rockville, MD 20852], - Melissa Troutman at: 317-324-0149 [Genetic Consultants of IN: 9595 Whitley Dr., Suite 205, Indianapolis, IN 46240], - Christy Diemond at: 425-402-4730 [Genetic Consultants of WA: 17311 135th Ave., NE, Suite B800 RM 8, Woodinville, WA 98072], or - Paul G. King at: 973-968-3351 [Genetic Consultants of NJ: 160 Littleton Rd., Suite 103A, Parsippany, NJ 07054]. The Autism Research Institute (ARI) and CoMeD are supporting this study. Your generous tax-free donations to ARI1 or CoMeD2 will help to fund additional research, similar to the present study, to establish appropriate curative therapies. 1 To support the ongoing efforts of the ARI, with your tax-deductible contributions, please visit their website, http://www.autism.com 2 To support the ongoing efforts of CoMeD, Inc. with your tax-deductible contributions, please use the PayPal link on CoMeD"s Internet website, http://www.Mercury-freeDrugs.org. CoMeD, Inc. is a not-for-profit 501(c)(3) corporation that is actively engaged in legal, educational and scientific efforts to stop all use of mercury in medicine, and to ban the use of all mercury-containing medicines as well as to establish proven curative or supportive therapies for those who have been harmed. ASD Centers, LLC


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009